Cargando…
Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m(6)A Regulators
BACKGROUND: Esophagus cancer (ESCA) is the sixth most frequent cancer in males, with 5-year overall survival of 15%–25%. RNA modifications function critically in cancer progression, and m(6)A regulators are associated with ESCA prognosis. This study further revealed correlations between m(6)A and ES...
Autores principales: | Li, Jianjun, Zhu, Hongbo, Yang, Qiao, Xiao, Hua, Wu, Haibiao, Fang, Zhe, Li, Wenjun, Cai, Manbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776445/ https://www.ncbi.nlm.nih.gov/pubmed/35069736 http://dx.doi.org/10.1155/2022/5490461 |
Ejemplares similares
-
Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma
por: Cai, Manbo, et al.
Publicado: (2023) -
Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment
por: Li, Aixin, et al.
Publicado: (2022) -
Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
por: Tang, Xin, et al.
Publicado: (2018) -
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes
por: Li, Renda, et al.
Publicado: (2021) -
Small Cell Carcinoma of the Esophagus
por: Chatni, Sanjeev S., et al.
Publicado: (2008)